The progression of semaglutide from a metabolic drug to a potential neuroprotective agent is ongoing, but its future role in neurology will likely focus on the prevention of neurodegeneration rather than the treatment of established diseases
In the STEP 1 trial published in The New England Journal of Medicine , people taking semaglutide lost more than 15% of their body weight over about 16 months
Subsequently, prostaglandin and thromboxane generated by cyclooxygenase as well as leukotrienes generated by lipoxygenase from arachidonate (20:4n-6) function as lipid mediators
This anti-apoptotic activity in lymphoid tissue contributes to preservation of immune system capacity during aging and environmental challenges
This article provides a step-by-step protocol for purifying antibodies using Protein A, Protein G, or Protein L magnetic agarose beads
Other causes include increased tear evaporation, mainly resulting from environmental factors like wind, smoke, dry air, and an imbalance in tear composition